ATR

AptarGroup, Inc.
$132.61
-2.14 (-1.59%)
Mkt Cap 8.46B
Volume 415,529
52W Range 103.23-164.28
Sector Healthcare
Beta 0.39
EPS (TTM) 5.91
P/E Ratio 22.44
Revenue (TTM) 3.87B
Rev Growth (5Y) +5.2%
EPS Growth (5Y) +12.5%
AlphaVal · Fair Value
What we estimate one share is worth
$109.24
Overvalued moderate signal
21.4% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B
Stable Earnings Power
70.5 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 3.78B 3.58B 3.49B 3.32B 3.23B 2.93B 2.86B 2.76B 2.47B 2.33B 2.32B 2.60B
Net Income 392.79M 374.54M 284.49M 239.29M 244.10M 214.04M 242.20M 194.75M 220.03M 205.59M 199.35M 191.66M
EPS 5.97 5.65 4.34 3.66 3.72 3.32 3.81 3.12 3.52 3.27 3.19 2.95
Free Cash Flow 299.58M 349.22M 256.84M 163.00M 55.51M 318.11M 267.38M 101.77M 168.10M 193.82M 174.44M 154.38M
FCF / Share 4.56 5.26 3.91 2.49 0.85 4.94 4.21 1.63 2.69 3.09 2.79 2.37
Operating CF 570.00M 643.41M 575.24M 478.62M 363.44M 570.15M 514.46M 313.63M 324.73M 325.30M 323.76M 316.33M
Total Assets 5.25B 4.43B 4.45B 4.20B 4.14B 3.99B 3.56B 3.38B 3.14B 2.61B 2.44B 2.44B
Total Debt 1.53B 1.08B 1.18B 1.22B 1.24B 1.23B 1.25B 1.29B 1.26B 948.10M 819.44M 843.29M
Cash & Equiv 402.42M 223.84M 223.64M 141.73M 122.92M 300.14M 241.97M 261.82M 712.64M 466.29M 489.90M 399.76M
Book Value 2.67B 2.47B 2.31B 2.05B 1.97B 1.85B 1.57B 1.42B 1.31B 1.17B 1.15B 1.10B
Return on Equity 0.15 0.15 0.12 0.12 0.12 0.12 0.15 0.14 0.17 0.18 0.17 0.17
ATR News
Chicago Partners Investment Group LLC Invests $505,000 in AptarGroup, Inc. $ATR
Jul 19, 2026 12:11 AM · defenseworld.net
Aptar Declares Quarterly Dividend
Jul 16, 2026 01:00 PM · businesswire.com
Will AptarGroup (ATR) Beat Estimates Again in Its Next Earnings Report?
Jul 16, 2026 09:11 AM · zacks.com
Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
Jul 14, 2026 02:30 AM · prnewswire.com
Aptar Releases 2025 Corporate Sustainability Report
Jun 18, 2026 01:00 PM · businesswire.com
AptarGroup, Inc. (ATR) Presents at 16th Annual Wells Fargo Industrials & Materials Conference Transcript
Jun 09, 2026 11:52 PM · seekingalpha.com
A Look at AptarGroup Inc (ATR) After 3.5% Gain -- GF Value $156.52 vs Price $115.90
Jun 09, 2026 03:56 PM · gurufocus.com
AptarGroup, Inc. (ATR) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Jun 03, 2026 11:52 AM · seekingalpha.com
Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year
Jun 02, 2026 01:00 PM · businesswire.com
Aptar to Participate in Upcoming Investor Conferences
May 27, 2026 01:00 PM · businesswire.com